Drug
D0028 | Ciprofibrate
C
C10AB08 Ciprofibrate
[C10AB] Fibrates
[C10A] LIPID MODIFYING AGENTS, PLAIN
[C10] LIPID MODIFYING AGENTS
[C] Cardiovascular system
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Danger |
Aggregated GHS information provided by 41 companies from 3 notifications to the ECHA C&L Inventory. H350 (92.68%): May cause cancer [Danger Carcinogenicity] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P281, P308+P313, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid | 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid | 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid |
| 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid | 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid | 2-[4-(2,2-dichlorocyclopropyl)phenoxy]isobutyric acid |
| 2-[4-[2,2-bis(chloranyl)cyclopropyl]phenoxy]-2-methyl-propanoic acid | 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid | 2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acid |
| 2-{4-[2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid | 2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid | 214C843 |
| 4CA-0385 | 52214-84-3 | A828985 |
| AB0010540 | AB00514032 | AB00514032_06 |
| AB2000704 | AC-1018 | AK-77509 |
| AKOS005557843 | ANW-46062 | AOB6803 |
| API0002026 | AX8121411 | BBL010821 |
| BCP03728 | BCP0726000148 | BCP9000533 |
| BCPP000277 | BDBM50371235 | BG0457 |
| BPBio1_001202 | BRD-A49358627-001-03-9 | BRD-A49358627-001-10-4 |
| BRN 1984981 | BSPBio_001092 | C 0330 |
| C-18160 | C13H14Cl2O3 | CAS-52214-84-3 |
| CC-25814 | CCG-204263 | CCRIS 173 |
| CHEBI:50867 | CHEMBL557555 | CS-2898 |
| CTK7I5107 | Ciprofibrate | Ciprofibrate (USAN/INN) |
| Ciprofibrate [USAN:BAN:INN] | Ciprofibrate [USAN:INN:BAN] | Ciprofibrate for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Ciprofibrate, European Pharmacopoeia (EP) Reference Standard | Ciprofibrate? | Ciprofibrato |
| Ciprofibrato [INN-Spanish] | Ciprofibratum | Ciprofibratum [INN-Latin] |
| Ciprol | D03521 | DSSTox_CID_331 |
| DSSTox_GSID_20331 | DSSTox_RID_75519 | DTXSID8020331 |
| EBD38709 | EINECS 257-744-6 | EU-0100168 |
| FT-0602946 | GTPL3438 | HMS1571G14 |
| HMS2098G14 | HMS2235J14 | HMS3260B17 |
| HMS3369B22 | HMS3656P09 | HMS3715G14 |
| HY-B0664 | Hiperlipen | J-520054 |
| KPSRODZRAIWAKH-UHFFFAOYSA-N | KS-00000FXC | KS-1201 |
| LP00168 | LS-7279 | Lipanor |
| Lopac0_000168 | MCULE-8060052925 | MFCD00467135 |
| MLS002154143 | MLS006011758 | Modalim |
| NCGC00015202-02 | NCGC00015202-03 | NCGC00015202-04 |
| NCGC00015202-05 | NCGC00015202-06 | NCGC00015202-08 |
| NCGC00093652-01 | NCGC00093652-02 | NCGC00164447-01 |
| NCGC00256361-01 | NCGC00258911-01 | NCGC00260853-01 |
| NSC-759617 | NSC759617 | Pharmakon1600-01502008 |
| Prestwick0_001076 | Prestwick1_001076 | Prestwick2_001076 |
| Prestwick3_001076 | Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl- | Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl- |
| Propionic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl- | Q3496452 | RT-004891 |
| SCHEMBL26870 | SMR000857190 | SPBio_002996 |
| SR-01000075734 | SR-01000075734-1 | SR-01000075734-4 |
| SR-01000075734-7 | ST24027521 | STK624758 |
| SW197242-4 | Tox21_112121 | Tox21_112121_1 |
| Tox21_201359 | Tox21_302840 | Tox21_500168 |
| WIN 35833 | Win 35,833 | Win-35833 |
| Win35833 | s2665 |
| DrugBank Name | Ciprofibrate |
| DrugBank | DB09064 |
| CAS Number | 52214-84-3 |
| PubChem Compound | 2763 |
| KEGG Drug | D03521 |
| ChEBI | 50867 |
| ChemSpider | 2661 |
| BindingDB | 50371235.0 |
| Wikipedia | Ciprofibrate |
1. Chan et al. (2005)
2. Brunmair et al. (2004)
3. Zhou et al. (1999)